HANGZHOU THINHEAL PHARMA-TECH CO LTD

Overview

HANGZHOU THINHEAL PHARMA-TECH CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering LINACLOTIDE; RETATRUTIDE; SEMAGLUTIDE; TIRZEPATIDE.

API / Drug Master Files

HANGZHOU THINHEAL PHARMA-TECH CO LTD holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • RETATRUTIDEActive2025-12-30
  • TIRZEPATIDEActive2024-06-28
  • LINACLOTIDEActive2024-06-28
  • SEMAGLUTIDEActive2024-06-28

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to HANGZHOU THINHEAL PHARMA-TECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.